InvestorsHub Logo
icon url

Learjetter

10/23/19 1:48 PM

#44653 RE: EOT #44649

Lol, there is zero basis for that claim. That is a guess at best. This is a scam fest. Based on efforts in the last year, it doesnt even make sense. PND into dilution. All you have here. They will dilute this to probably. 0003, or just before 2019 levels, they still wont have the funding to move this into trials. It's a flippers scam. All fake. All IMO.

all a game!!
icon url

EOT

10/23/19 1:55 PM

#44654 RE: EOT #44649

Huge opportunity here.....


Clinical trials have BEGUN on 3 types of cancer!!
Last PR.....

“today announced that it HAS INITIATED STUDIES of Adva-27a in xenograft mice”

. In these studies, specifically engineered mice which have developed tumors following injection with patient derived cancer cells are treated with Adva-27a to assess the ability of the drug to shrink the tumors.

Among the different types of patient derived cancer types being studied are Pancreatic Cancer, Breast Cancer, Small-Cell Lung Cancer and Uterine Sarcoma.
About Adva-27a